SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Procter & Gamble Co. – ‘10-Q’ for 9/30/22 – ‘EX-31.1’

On:  Wednesday, 10/19/22, at 4:16pm ET   ·   For:  9/30/22   ·   Accession #:  80424-22-102   ·   File #:  1-00434

Previous ‘10-Q’:  ‘10-Q’ on 4/20/22 for 3/31/22   ·   Next:  ‘10-Q’ on 1/19/23 for 12/31/22   ·   Latest:  ‘10-Q’ on 4/19/24 for 3/31/24   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/19/22  Procter & Gamble Co.              10-Q        9/30/22   51:4.9M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Fy2223 Q1 Jas 10-Q                                  HTML   1.06M 
 2: EX-31.1     Rule 13A-14(A)/15D-14(A) Certification Chief        HTML     21K 
                Executive Officer                                                
 3: EX-31.2     Rule 13A-14(A)/15D-14(A) Certification Chief        HTML     21K 
                Financial Officer                                                
 4: EX-32.1     Section 1350 Certifications Chief Executive         HTML     18K 
                Officer                                                          
 5: EX-32.2     Section 1350 Certifications Chief Financial         HTML     17K 
                Officer                                                          
11: R1          Document and Entity Information                     HTML    108K 
12: R2          Consolidated Statements of Earnings                 HTML     92K 
13: R3          Condolidated Statements of Comprehensive Income     HTML     51K 
14: R4          Consolidated Balance Sheets                         HTML    138K 
15: R5          Consolidated Statements of Shareholders' Equity     HTML     89K 
16: R6          Consolidated Statements of Cash Flows               HTML     95K 
17: R7          Basis of Presentation                               HTML     19K 
18: R8          New Accounting Pronouncements and Policies          HTML     30K 
19: R9          Segment Information                                 HTML     70K 
20: R10         Goodwill and Other Intangible Assets                HTML     51K 
21: R11         Earnings Per Share                                  HTML     42K 
22: R12         Share-Based Compensation and Postretirement         HTML     25K 
                Benefits                                                         
23: R13         Risk Management Activities and Fair Value           HTML     64K 
                Measurements                                                     
24: R14         Accumulated Other Comprehensive Income (Loss)       HTML     38K 
25: R15         Commitments and Contingencies                       HTML     22K 
26: R16         Segment Reporting (Tables)                          HTML     64K 
27: R17         Goodwill and Other Intangible Assets (Tables)       HTML     51K 
28: R18         Earnings Per Share (Tables)                         HTML     41K 
29: R19         Share-Based Compensation and Postretirement         HTML     24K 
                Benefits (Tables)                                                
30: R20         Risk Management Activities and Fair Value           HTML     66K 
                Measurements (Tables)                                            
31: R21         Accumulated Other Comprehensive Income (Loss)       HTML     36K 
                (Tables)                                                         
32: R22         Segment Information - Sales (Details)               HTML     45K 
33: R23         Segment Information (Details)                       HTML     52K 
34: R24         Goodwill and Other Intangible Assets - Change in    HTML     39K 
                the Net Carrying Amount of Goodwill by Global                    
                Business Unit (Details)                                          
35: R25         Goodwill and Other Intangible Assets -              HTML     26K 
                Identifiable Intangible Assets (Details)                         
36: R26         Goodwill and Other Intangible Assets - Fair Value   HTML     26K 
                Sensitivity (Details)                                            
37: R27         Goodwill and Other Intangible Assets - Additional   HTML     30K 
                Information (Details)                                            
38: R28         Earnings Per Share (Details)                        HTML     71K 
39: R29         Earnings Per Share - Antidilutive Securities        HTML     21K 
                (Details)                                                        
40: R30         Share-Based Compensation and Postretirement         HTML     27K 
                Benefits (Details)                                               
41: R31         Risk Management Activities and Fair Value           HTML     38K 
                Measurements - Schedule of Derivative Instruments                
                (Details)                                                        
42: R32         Risk Management Activities and Fair Value           HTML     28K 
                Measurements - Derivative Instruments, Effect on                 
                Other Comprehensive Income (Loss) (Details)                      
43: R33         Risk Management Activities and Fair Value           HTML     25K 
                Measurements - Derivative Instruments Gain (Loss)                
                (Details)                                                        
44: R34         Risk Management Activities and Fair Value           HTML     42K 
                Measurements - Additional Information (Details)                  
45: R35         Accumulated Other Comprehensive Income (Loss) -     HTML     57K 
                Changes in Aoci and Reclassification Out of Aoci                 
                (Details)                                                        
46: R36         Commitments and Contingencies - Additional          HTML     27K 
                Information (Details)                                            
49: XML         IDEA XML File -- Filing Summary                      XML     86K 
47: XML         XBRL Instance -- pg-20220930_htm                     XML   1.23M 
48: EXCEL       IDEA Workbook of Financial Reports                  XLSX     78K 
 7: EX-101.CAL  XBRL Calculations -- pg-20220930_cal                 XML    126K 
 8: EX-101.DEF  XBRL Definitions -- pg-20220930_def                  XML    432K 
 9: EX-101.LAB  XBRL Labels -- pg-20220930_lab                       XML   1.01M 
10: EX-101.PRE  XBRL Presentations -- pg-20220930_pre                XML    579K 
 6: EX-101.SCH  XBRL Schema -- pg-20220930                           XSD    103K 
50: JSON        XBRL Instance as JSON Data -- MetaLinks              294±   420K 
51: ZIP         XBRL Zipped Folder -- 0000080424-22-000102-xbrl      Zip    272K 


‘EX-31.1’   —   Rule 13A-14(A)/15D-14(A) Certification Chief Executive Officer


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 31.1
Rule 13a-14(a)/15d-14(a) Certifications
I, Jon R. Moeller, certify that:
(1)I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ JON R. MOELLER
(Jon R. Moeller)
Chairman of the Board, President and Chief Executive Officer
October 19, 2022
Date




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/19/228-K
For Period end:9/30/22
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/26/23  Procter & Gamble Co.              424B5                  2:464K                                   Donnelley … Solutions/FA
 4/24/23  Procter & Gamble Co.              424B5                  1:417K                                   Donnelley … Solutions/FA
 2/28/23  Procter & Gamble Co.              S-8         2/28/23    7:8.8M
 1/31/23  Procter & Gamble Co.              424B5                  2:409K                                   Donnelley … Solutions/FA
 1/27/23  Procter & Gamble Co.              424B5                  1:388K                                   Donnelley … Solutions/FA
 1/25/23  Procter & Gamble Co.              424B5                  2:448K                                   Donnelley … Solutions/FA
 1/23/23  Procter & Gamble Co.              424B5                  1:406K                                   Donnelley … Solutions/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/16  Procter & Gamble Co.              10-K        6/30/16  128:17M
Top
Filing Submission 0000080424-22-000102   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 1:34:03.1pm ET